← Portfolio Scout

Portfolio company

EnPlusOne

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep Tech

About

This company develops enzymatic RNA synthesis technology for biotechnology firms and pharmaceutical manufacturers to produce oligonucleotides for therapeutic applications.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies